Paragon 28, Inc. (NYSE:FNA – Get Free Report) has earned a consensus rating of “Hold” from the six ratings firms that are presently covering the company, Ratings reports. Four research analysts have ...

Paragon 28 (FNA – Research Report) received a Hold rating and price target from Needham analyst Michael Matson today. The company’s shares ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $13.4, a ...

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Paragon 28, Inc. (NYSE: FNA), a leading medical device company focused exclusively on the foot and ankle ...

Zimmer Biomet to buy medical device company, Paragon 28 for $1.2 billion: Warsaw, Indiana Thursday, January 30, 2025, 14:00 Hrs [IST] Zimmer Biomet Holdings, Inc., a global medica ...

Jan. 28, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX ... Established in 2010, Paragon 28 has an extensive suite of surgical offerings and product systems spanning all major foot ...

HERNDON, Va., Jan. 23, 2025 /PRNewswire/ -- Paragon Systems, Inc. is proud to announce its selection as a Prime Contractor on the Department of Defense (DOD) Department of the Navy (DON ...

Inc. has announced Tuesday evening plans to acquire Paragon 28, Inc. (Paragon 28), a move that Moody's (NYSE:MCO) Ratings ...